{
  "run": {
    "id": "cmnr12lb902i2p6584m07cp31",
    "region": "US",
    "assetId": "cmnr12laj02hyp658ufh2qab9",
    "ticker": "BRO",
    "snapshotId": "cmnr12lau02i0p658o6betlua",
    "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux",
    "createdAt": "2026-04-09T05:19:51.139Z",
    "promptTemplate": {
      "id": "cmnqt07si0005lm3jzpxuu1ux",
      "name": "Oficial 08.apr.2026",
      "version": 1
    },
    "snapshot": {
      "id": "cmnr12lau02i0p658o6betlua",
      "assetId": "cmnr12laj02hyp658ufh2qab9",
      "asOf": "2026-04-08T20:00:02.000Z",
      "snapshot": {
        "asOf": "2026-04-08T20:00:02.000Z",
        "quote": {
          "asOf": "2026-04-08T20:00:02.000Z",
          "open": null,
          "price": 67.76,
          "dayLow": 65.92,
          "volume": 2252738,
          "dayHigh": 67.865,
          "currency": "USD",
          "prevClose": 66.37,
          "week52Low": 63.29,
          "week52High": 121.7
        },
        "fundamentals": {
          "pe": 23.6498516320475,
          "beta": 0.708144763445401,
          "epsTTM": 3.37,
          "fcfTTM": 1090000000,
          "growth": {
            "epsYoy": -0.03160919540229881,
            "revenueYoy": 0.2283038501560874
          },
          "sector": "Insurance Agents, Brokers & Service",
          "margins": {
            "net": 0.1785835310064385,
            "gross": null,
            "operating": null
          },
          "website": "http://bbrown.com",
          "industry": null,
          "pegRatio": -7.48195306177504,
          "ebitdaTTM": 2034000000,
          "forwardPe": 17.5164835164835,
          "marketCap": 31616025136,
          "totalCash": 1079000000,
          "totalDebt": 8332000000,
          "debtEquity": 0.662689891036348,
          "quickRatio": 0.1300940438871473,
          "revenueTTM": 5902000000,
          "companyName": "BROWN & BROWN, INC.",
          "priceToBook": 0.856692094313454,
          "currentRatio": 1.038582107547625,
          "dividendYield": 0.00781155138219938,
          "returnOnAssets": 0.03514387649628222,
          "returnOnEquity": 0.0838304302871232,
          "analystOpinions": null,
          "businessSummary": "Brown & Brown, Inc. is an American insurance brokerage firm headquartered in Daytona Beach, Florida. It is one of the largest independent insurance intermediaries in the United States, providing risk management solutions, insurance products, and services to businesses, governmental institutions, professional organizations, trade associations, and individuals.",
          "enterpriseValue": 31960000000,
          "analystTargetLow": null,
          "analystTargetHigh": null,
          "analystTargetMean": null,
          "fullTimeEmployees": 17403,
          "sharesOutstanding": 340420023,
          "enterpriseToEbitda": 15.71288102261554,
          "analystTargetMedian": null,
          "enterpriseToRevenue": 5.415113520840393,
          "operatingCashflowTTM": 1450000000,
          "analystRecommendationKey": null
        }
      },
      "createdAt": "2026-04-09T05:19:51.126Z"
    },
    "results": [
      {
        "id": "cmnr12lbc02i4p658lvc9vltd",
        "runId": "cmnr12lb902i2p6584m07cp31",
        "modelId": "anthropic",
        "status": "SUCCESS",
        "rawOutput": "{\"model\":\"ai-equity-research-v1\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"BRO\",\"currency\":\"USD\",\"current_price\":67.76,\"target_price_6m\":74.5,\"target_price_12m\":80.0,\"recommendation\":\"BUY\",\"confidence\":0.62,\"thesis_bullets\":[\"Stock ~44% off 52-week high creates potential entry point for quality broker\",\"Forward P/E of 17.5x implies meaningful EPS growth ahead of integration benefits\",\"Revenue grew 22.8% YoY driven by McGriff acquisition and organic growth\",\"Price-to-book below 1.0 is unusually cheap for a top-tier insurance intermediary\",\"High debt load and EPS compression temper near-term enthusiasm\"],\"key_drivers\":[{\"driver\":\"Insurance brokerage organic revenue growth (~5-7% range)\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"McGriff acquisition integration and synergy realization\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Elevated debt from M&A ($8.3B) weighing on earnings and sentiment\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Hard insurance market supporting commission growth\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"EPS declined 3.2% YoY despite strong revenue growth\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Resilient FCF generation ($1.09B TTM) supports deleveraging\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Low beta (0.71) offers relative defensiveness in volatile markets\",\"impact\":\"LOW\",\"direction\":\"POS\"},{\"driver\":\"Quick ratio of 0.13 signals tight near-term liquidity\",\"impact\":\"MED\",\"direction\":\"NEG\"}],\"risks\":[\"Integration risk from large McGriff acquisition could delay synergy targets\",\"Elevated leverage ($8.3B debt) limits financial flexibility and increases interest costs\",\"Potential softening in P&C pricing cycle would pressure organic growth\",\"Rising interest rates increase refinancing costs on acquisition debt\",\"Macro downturn could reduce insurable exposures and commercial insurance demand\",\"Goodwill impairment risk if acquired businesses underperform\"],\"assumptions\":{\"revenue_cagr_3y\":0.08,\"ebit_margin_target\":0.27,\"wacc\":0.095,\"terminal_multiple\":18.0},\"scenarios\":{\"bear\":{\"target_price\":56.0,\"prob\":0.2,\"notes\":\"Integration delays, margin compression, and macro weakness push multiple to ~15x forward EPS.\"},\"base\":{\"target_price\":80.0,\"prob\":0.55,\"notes\":\"Steady integration, organic growth ~6%, and moderate margin improvement drive re-rating to ~19x forward EPS.\"},\"bull\":{\"target_price\":100.0,\"prob\":0.25,\"notes\":\"Faster-than-expected synergies, hard market persists, deleveraging accelerates, multiple expands to ~23x forward EPS.\"}},\"method_notes\":\"Valuation anchored on forward P/E using implied forward EPS of ~$3.87 and normalized multiple range for insurance brokers (15-23x). Stock's ~44% decline from 52w high appears overdone relative to fundamentals; FCF yield ~3.4% supports deleveraging path. Debt-adjusted return framework and EV/EBITDA (15.7x) cross-checked. Base 12M target of $80 implies ~18% upside, consistent with BUY. Confidence moderate (0.62) due to integration uncertainty and leverage. Not investment advice.\"}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "ai-equity-research-v1",
          "risks": [
            "Integration risk from large McGriff acquisition could delay synergy targets",
            "Elevated leverage ($8.3B debt) limits financial flexibility and increases interest costs",
            "Potential softening in P&C pricing cycle would pressure organic growth",
            "Rising interest rates increase refinancing costs on acquisition debt",
            "Macro downturn could reduce insurable exposures and commercial insurance demand",
            "Goodwill impairment risk if acquired businesses underperform"
          ],
          "ticker": "BRO",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.55,
              "notes": "Steady integration, organic growth ~6%, and moderate margin improvement drive re-rating to ~19x forward EPS.",
              "target_price": 80
            },
            "bear": {
              "prob": 0.2,
              "notes": "Integration delays, margin compression, and macro weakness push multiple to ~15x forward EPS.",
              "target_price": 56
            },
            "bull": {
              "prob": 0.25,
              "notes": "Faster-than-expected synergies, hard market persists, deleveraging accelerates, multiple expands to ~23x forward EPS.",
              "target_price": 100
            }
          },
          "confidence": 0.62,
          "assumptions": {
            "wacc": 0.095,
            "revenue_cagr_3y": 0.08,
            "terminal_multiple": 18,
            "ebit_margin_target": 0.27
          },
          "key_drivers": [
            {
              "driver": "Insurance brokerage organic revenue growth (~5-7% range)",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "McGriff acquisition integration and synergy realization",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Elevated debt from M&A ($8.3B) weighing on earnings and sentiment",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Hard insurance market supporting commission growth",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "EPS declined 3.2% YoY despite strong revenue growth",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Resilient FCF generation ($1.09B TTM) supports deleveraging",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Low beta (0.71) offers relative defensiveness in volatile markets",
              "impact": "LOW",
              "direction": "POS"
            },
            {
              "driver": "Quick ratio of 0.13 signals tight near-term liquidity",
              "impact": "MED",
              "direction": "NEG"
            }
          ],
          "method_notes": "Valuation anchored on forward P/E using implied forward EPS of ~$3.87 and normalized multiple range for insurance brokers (15-23x). Stock's ~44% decline from 52w high appears overdone relative to fundamentals; FCF yield ~3.4% supports deleveraging path. Debt-adjusted return framework and EV/EBITDA (15.7x) cross-checked. Base 12M target of $80 implies ~18% upside, consistent with BUY. Confidence moderate (0.62) due to integration uncertainty and leverage. Not investment advice.",
          "current_price": 67.76,
          "recommendation": "BUY",
          "thesis_bullets": [
            "Stock ~44% off 52-week high creates potential entry point for quality broker",
            "Forward P/E of 17.5x implies meaningful EPS growth ahead of integration benefits",
            "Revenue grew 22.8% YoY driven by McGriff acquisition and organic growth",
            "Price-to-book below 1.0 is unusually cheap for a top-tier insurance intermediary",
            "High debt load and EPS compression temper near-term enthusiasm"
          ],
          "target_price_6m": 74.5,
          "target_price_12m": 80
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "provider": "anthropic",
            "webSearch": {
              "enabled": false,
              "maxToolCalls": 2,
              "disabledReason": null
            },
            "pauseTurns": 0,
            "stopReason": "end_turn"
          },
          "sanityIssues": []
        },
        "latencyMs": 42584,
        "createdAt": "2026-04-09T05:19:51.139Z",
        "usage": {
          "inputTokens": 3573,
          "outputTokens": 1935,
          "costUsd": 0.06624
        }
      },
      {
        "id": "cmnr12lbc02i7p658x507q682",
        "runId": "cmnr12lb902i2p6584m07cp31",
        "modelId": "deepseek.reasoner",
        "status": "SUCCESS",
        "rawOutput": "{\n  \"model\": \"AI Equity Research Model\",\n  \"as_of\": \"2026-04-08T20:00:02.000Z\",\n  \"ticker\": \"BRO\",\n  \"currency\": \"USD\",\n  \"current_price\": 67.76,\n  \"target_price_6m\": 75.0,\n  \"target_price_12m\": 79.1,\n  \"recommendation\": \"BUY\",\n  \"confidence\": 0.65,\n  \"thesis_bullets\": [\n    \"Strong revenue growth of 22.83% YoY.\",\n    \"P/B ratio below 1 suggests undervaluation.\",\n    \"EPS decline indicates profitability concerns.\",\n    \"Market leadership provides business stability.\",\n    \"Balanced risk-reward with mixed metrics.\"\n  ],\n  \"key_drivers\": [\n    {\"driver\": \"Revenue Growth\", \"impact\": \"HIGH\", \"direction\": \"POS\"},\n    {\"driver\": \"EPS Trend\", \"impact\": \"MED\", \"direction\": \"NEG\"},\n    {\"driver\": \"P/B Ratio\", \"impact\": \"HIGH\", \"direction\": \"POS\"},\n    {\"driver\": \"Debt Levels\", \"impact\": \"MED\", \"direction\": \"NEG\"},\n    {\"driver\": \"Return on Equity\", \"impact\": \"MED\", \"direction\": \"POS\"},\n    {\"driver\": \"Industry Competition\", \"impact\": \"MED\", \"direction\": \"NEG\"},\n    {\"driver\": \"Economic Conditions\", \"impact\": \"HIGH\", \"direction\": \"NEG\"},\n    {\"driver\": \"Acquisition Strategy\", \"impact\": \"MED\", \"direction\": \"POS\"}\n  ],\n  \"risks\": [\n    \"Margin compression from cost increases.\",\n    \"Economic downturn reducing insurance demand.\",\n    \"Regulatory changes in insurance sector.\",\n    \"Integration risks from acquisitions.\"\n  ],\n  \"assumptions\": {\n    \"revenue_cagr_3y\": 0.12,\n    \"ebit_margin_target\": 0.20,\n    \"wacc\": 0.08,\n    \"terminal_multiple\": 1.0\n  },\n  \"scenarios\": {\n    \"bear\": {\"target_price\": 70.0, \"prob\": 0.2, \"notes\": \"Economic slowdown impacts growth.\"},\n    \"base\": {\"target_price\": 79.1, \"prob\": 0.5, \"notes\": \"Steady performance with P/B normalization.\"},\n    \"bull\": {\"target_price\": 85.0, \"prob\": 0.3, \"notes\": \"Strong execution and market share gains.\"}\n  },\n  \"method_notes\": \"Valuation based on P/B normalization and earnings growth. Mixed evidence leads to BUY with medium confidence. Not investment advice.\"\n}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "AI Equity Research Model",
          "risks": [
            "Margin compression from cost increases.",
            "Economic downturn reducing insurance demand.",
            "Regulatory changes in insurance sector.",
            "Integration risks from acquisitions."
          ],
          "ticker": "BRO",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.5,
              "notes": "Steady performance with P/B normalization.",
              "target_price": 79.1
            },
            "bear": {
              "prob": 0.2,
              "notes": "Economic slowdown impacts growth.",
              "target_price": 70
            },
            "bull": {
              "prob": 0.3,
              "notes": "Strong execution and market share gains.",
              "target_price": 85
            }
          },
          "confidence": 0.65,
          "assumptions": {
            "wacc": 0.08,
            "revenue_cagr_3y": 0.12,
            "terminal_multiple": 1,
            "ebit_margin_target": 0.2
          },
          "key_drivers": [
            {
              "driver": "Revenue Growth",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "EPS Trend",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "P/B Ratio",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Debt Levels",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Return on Equity",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Industry Competition",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Economic Conditions",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Acquisition Strategy",
              "impact": "MED",
              "direction": "POS"
            }
          ],
          "method_notes": "Valuation based on P/B normalization and earnings growth. Mixed evidence leads to BUY with medium confidence. Not investment advice.",
          "current_price": 67.76,
          "recommendation": "BUY",
          "thesis_bullets": [
            "Strong revenue growth of 22.83% YoY.",
            "P/B ratio below 1 suggests undervaluation.",
            "EPS decline indicates profitability concerns.",
            "Market leadership provides business stability.",
            "Balanced risk-reward with mixed metrics."
          ],
          "target_price_6m": 75,
          "target_price_12m": 79.1
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "endpoint": "https://api.deepseek.com/v1/chat/completions",
            "provider": "deepseek",
            "webSearch": {
              "enabled": false,
              "supported": false
            },
            "responseFormat": "json_object"
          },
          "sanityIssues": []
        },
        "latencyMs": 389,
        "createdAt": "2026-04-09T05:19:51.139Z",
        "usage": {
          "inputTokens": 2084,
          "outputTokens": 4908,
          "costUsd": 0.002645
        }
      },
      {
        "id": "cmnr12lbc02i5p6584p3gavxy",
        "runId": "cmnr12lb902i2p6584m07cp31",
        "modelId": "gemini.3-pro",
        "status": "SUCCESS",
        "rawOutput": "{\n  \"model\": \"EquityResearch_Broker_v1\",\n  \"as_of\": \"2026-04-08T20:00:02.000Z\",\n  \"ticker\": \"BRO\",\n  \"currency\": \"USD\",\n  \"current_price\": 67.76,\n  \"target_price_6m\": 73.00,\n  \"target_price_12m\": 78.00,\n  \"recommendation\": \"BUY\",\n  \"confidence\": 0.70,\n  \"thesis_bullets\": [\n    \"Strong top-line growth of 22.8% highlights robust organic and M&A-driven expansion.\",\n    \"Recent EPS contraction (-3.1%) suggests near-term margin pressure or integration headwinds.\",\n    \"Forward P/E of 17.5x offers an attractive entry point for a defensive compounder.\",\n    \"Stock is trading near 52-week lows, pricing in overly pessimistic softening cycle risks.\",\n    \"Consistent free cash flow generation ($1.09B TTM) supports ongoing M&A and dividend growth.\"\n  ],\n  \"key_drivers\": [\n    {\n      \"driver\": \"P&C Insurance Pricing Cycle\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"M&A Integration Costs\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Organic Revenue Growth\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Fiduciary Investment Income\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"EBITDA Margin Expansion\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Wage Inflation\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    }\n  ],\n  \"risks\": [\n    \"Faster-than-expected softening of commercial P&C insurance rates.\",\n    \"Integration risks and potential overpayment for recent acquisitions.\",\n    \"Macroeconomic slowdown reducing client payrolls and insured exposures.\",\n    \"Persistent wage inflation compressing operating margins.\"\n  ],\n  \"assumptions\": {\n    \"revenue_cagr_3y\": 0.085,\n    \"ebit_margin_target\": 0.32,\n    \"wacc\": 0.075,\n    \"terminal_multiple\": 18.0\n  },\n  \"scenarios\": {\n    \"bear\": {\n      \"target_price\": 58.00,\n      \"prob\": 0.25,\n      \"notes\": \"Softening P&C rates and margin compression drive multiple down to 15x forward earnings.\"\n    },\n    \"base\": {\n      \"target_price\": 78.00,\n      \"prob\": 0.55,\n      \"notes\": \"Steady organic growth and margin stabilization support a reversion to 20x forward P/E.\"\n    },\n    \"bull\": {\n      \"target_price\": 90.00,\n      \"prob\": 0.20,\n      \"notes\": \"Hard market persists, accretive M&A continues, and multiple expands to 23x.\"\n    }\n  },\n  \"method_notes\": \"Valuation based on a blend of historical P/E reversion (20x forward) and DCF. The ~15% upside supports a BUY rating, balancing strong revenue growth against recent EPS contraction. Not investment advice.\"\n}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "EquityResearch_Broker_v1",
          "risks": [
            "Faster-than-expected softening of commercial P&C insurance rates.",
            "Integration risks and potential overpayment for recent acquisitions.",
            "Macroeconomic slowdown reducing client payrolls and insured exposures.",
            "Persistent wage inflation compressing operating margins."
          ],
          "ticker": "BRO",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.55,
              "notes": "Steady organic growth and margin stabilization support a reversion to 20x forward P/E.",
              "target_price": 78
            },
            "bear": {
              "prob": 0.25,
              "notes": "Softening P&C rates and margin compression drive multiple down to 15x forward earnings.",
              "target_price": 58
            },
            "bull": {
              "prob": 0.2,
              "notes": "Hard market persists, accretive M&A continues, and multiple expands to 23x.",
              "target_price": 90
            }
          },
          "confidence": 0.7,
          "assumptions": {
            "wacc": 0.075,
            "revenue_cagr_3y": 0.085,
            "terminal_multiple": 18,
            "ebit_margin_target": 0.32
          },
          "key_drivers": [
            {
              "driver": "P&C Insurance Pricing Cycle",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "M&A Integration Costs",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Organic Revenue Growth",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Fiduciary Investment Income",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "EBITDA Margin Expansion",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Wage Inflation",
              "impact": "MED",
              "direction": "NEG"
            }
          ],
          "method_notes": "Valuation based on a blend of historical P/E reversion (20x forward) and DCF. The ~15% upside supports a BUY rating, balancing strong revenue growth against recent EPS contraction. Not investment advice.",
          "current_price": 67.76,
          "recommendation": "BUY",
          "thesis_bullets": [
            "Strong top-line growth of 22.8% highlights robust organic and M&A-driven expansion.",
            "Recent EPS contraction (-3.1%) suggests near-term margin pressure or integration headwinds.",
            "Forward P/E of 17.5x offers an attractive entry point for a defensive compounder.",
            "Stock is trading near 52-week lows, pricing in overly pessimistic softening cycle risks.",
            "Consistent free cash flow generation ($1.09B TTM) supports ongoing M&A and dividend growth."
          ],
          "target_price_6m": 73,
          "target_price_12m": 78
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "model": "gemini-3-pro-preview",
            "provider": "gemini",
            "webSearch": {
              "used": false,
              "allowed": false,
              "enabled": false,
              "requested": false,
              "disabledReason": null
            }
          },
          "sanityIssues": []
        },
        "latencyMs": 22518,
        "createdAt": "2026-04-09T05:19:51.139Z",
        "usage": {
          "inputTokens": 2419,
          "outputTokens": 852,
          "costUsd": 0.015062
        }
      },
      {
        "id": "cmnr12lbc02i3p658lajq2wh4",
        "runId": "cmnr12lb902i2p6584m07cp31",
        "modelId": "openai.gpt-5.4",
        "status": "SUCCESS",
        "rawOutput": "{\"model\":\"AI Model Recommendation\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"BRO\",\"currency\":\"USD\",\"current_price\":67.76,\"target_price_6m\":69,\"target_price_12m\":70.5,\"recommendation\":\"HOLD\",\"confidence\":0.61,\"thesis_bullets\":[\"Scale broker with recurring commissions supports resilient cash generation.\",\"Revenue growth is strong, but EPS dipped, signaling cost pressure.\",\"Forward P/E is below trailing, suggesting expectations already reset.\",\"Healthy FCF and manageable leverage support ongoing bolt-on acquisitions.\",\"After the sharp reset, shares look nearer fair value than cheap.\"],\"key_drivers\":[{\"driver\":\"Organic commission growth\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Bolt-on acquisition pipeline\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Commercial insurance pricing\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Fiduciary interest income\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Compensation expense inflation\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Integration execution\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Debt servicing costs\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Economic exposure of clients\",\"impact\":\"MED\",\"direction\":\"NEG\"}],\"risks\":[\"Organic growth slows as insured values or exposures weaken.\",\"Acquisition integration underdelivers or deal pricing stays elevated.\",\"Expense inflation compresses margins longer than expected.\",\"Insurance pricing softens, reducing commission tailwinds.\"],\"assumptions\":{\"revenue_cagr_3y\":9.5,\"ebit_margin_target\":31.5,\"wacc\":8.4,\"terminal_multiple\":17},\"scenarios\":{\"bear\":{\"target_price\":58,\"prob\":0.25,\"notes\":\"Organic growth normalizes quickly and margin pressure persists.\"},\"base\":{\"target_price\":70.5,\"prob\":0.5,\"notes\":\"Mid-single-digit organic growth and steady acquisition execution.\"},\"bull\":{\"target_price\":84,\"prob\":0.25,\"notes\":\"Stronger pricing, higher interest income, and cleaner margin recovery.\"}},\"method_notes\":\"Blended earnings-power and EV/EBITDA approach using snapshot fields; no sell-side targets used. Snapshot P/B appears atypically low for a broker, so FCF, forward P/E, and EV/EBITDA were weighted more heavily. HOLD matches roughly 4% 12M upside with mixed growth/margin signals; not investment advice.\"}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "AI Model Recommendation",
          "risks": [
            "Organic growth slows as insured values or exposures weaken.",
            "Acquisition integration underdelivers or deal pricing stays elevated.",
            "Expense inflation compresses margins longer than expected.",
            "Insurance pricing softens, reducing commission tailwinds."
          ],
          "ticker": "BRO",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.5,
              "notes": "Mid-single-digit organic growth and steady acquisition execution.",
              "target_price": 70.5
            },
            "bear": {
              "prob": 0.25,
              "notes": "Organic growth normalizes quickly and margin pressure persists.",
              "target_price": 58
            },
            "bull": {
              "prob": 0.25,
              "notes": "Stronger pricing, higher interest income, and cleaner margin recovery.",
              "target_price": 84
            }
          },
          "confidence": 0.61,
          "assumptions": {
            "wacc": 8.4,
            "revenue_cagr_3y": 9.5,
            "terminal_multiple": 17,
            "ebit_margin_target": 31.5
          },
          "key_drivers": [
            {
              "driver": "Organic commission growth",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Bolt-on acquisition pipeline",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Commercial insurance pricing",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Fiduciary interest income",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Compensation expense inflation",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Integration execution",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Debt servicing costs",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Economic exposure of clients",
              "impact": "MED",
              "direction": "NEG"
            }
          ],
          "method_notes": "Blended earnings-power and EV/EBITDA approach using snapshot fields; no sell-side targets used. Snapshot P/B appears atypically low for a broker, so FCF, forward P/E, and EV/EBITDA were weighted more heavily. HOLD matches roughly 4% 12M upside with mixed growth/margin signals; not investment advice.",
          "current_price": 67.76,
          "recommendation": "HOLD",
          "thesis_bullets": [
            "Scale broker with recurring commissions supports resilient cash generation.",
            "Revenue growth is strong, but EPS dipped, signaling cost pressure.",
            "Forward P/E is below trailing, suggesting expectations already reset.",
            "Healthy FCF and manageable leverage support ongoing bolt-on acquisitions.",
            "After the sharp reset, shares look nearer fair value than cheap."
          ],
          "target_price_6m": 69,
          "target_price_12m": 70.5
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "provider": "openai",
            "webSearch": {
              "used": false,
              "enabled": false,
              "sources": [],
              "maxToolCalls": 2
            },
            "responseId": "resp_0119021cfb1942ed0069d756b204808194af60efab73d85201",
            "reasoningEffort": "medium",
            "structuredOutputs": {
              "used": true,
              "requested": true,
              "disabledReason": null
            }
          },
          "sanityIssues": []
        },
        "latencyMs": 31335,
        "createdAt": "2026-04-09T05:19:51.139Z",
        "usage": {
          "inputTokens": 2354,
          "outputTokens": 1639,
          "costUsd": 0.027065
        }
      },
      {
        "id": "cmnr12lbc02i6p658826s7uys",
        "runId": "cmnr12lb902i2p6584m07cp31",
        "modelId": "xai.grok-4.20-reasoning",
        "status": "SUCCESS",
        "rawOutput": "{\n  \"model\": \"DCF Valuation Model\",\n  \"as_of\": \"2026-04-08T20:00:02.000Z\",\n  \"ticker\": \"BRO\",\n  \"currency\": \"USD\",\n  \"current_price\": 67.76,\n  \"target_price_6m\": 73,\n  \"target_price_12m\": 80,\n  \"recommendation\": \"BUY\",\n  \"confidence\": 0.62,\n  \"thesis_bullets\": [\n    \"Strong revenue growth of 23% yoy from organic and M&A\",\n    \"Stable business model with recurring revenue streams\",\n    \"Forward PE of 17.5x appears reasonable for growth profile\",\n    \"Low beta of 0.7 offers portfolio diversification\",\n    \"Robust cash flow funds dividends and debt management\"\n  ],\n  \"key_drivers\": [\n    {\n      \"driver\": \"Organic revenue growth\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Strategic acquisitions\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Rising insurance premiums\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Economic downturn impact\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Margin expansion\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Debt levels and interest costs\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Competitive landscape\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Regulatory environment\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    }\n  ],\n  \"risks\": [\n    \"Integration failures from aggressive M&A strategy\",\n    \"Prolonged economic recession reducing client spending\",\n    \"Increased competition eroding market share\",\n    \"Regulatory shifts increasing compliance costs\",\n    \"Interest rate volatility affecting debt servicing\"\n  ],\n  \"assumptions\": {\n    \"revenue_cagr_3y\": 0.14,\n    \"ebit_margin_target\": 0.3,\n    \"wacc\": 0.085,\n    \"terminal_multiple\": 19\n  },\n  \"scenarios\": {\n    \"bear\": {\n      \"target_price\": 58,\n      \"prob\": 0.25,\n      \"notes\": \"Growth slows amid recession and acquisition challenges.\"\n    },\n    \"base\": {\n      \"target_price\": 80,\n      \"prob\": 0.5,\n      \"notes\": \"Consistent execution on organic growth and M&A.\"\n    },\n    \"bull\": {\n      \"target_price\": 98,\n      \"prob\": 0.25,\n      \"notes\": \"Accelerated growth from strong insurance market.\"\n    }\n  },\n  \"method_notes\": \"DCF using 14% revenue CAGR, 30% EBIT margin, 8.5% WACC and 19x terminal multiple. 18% 12M upside supports BUY. Consensus noted but not used in targets. not investment advice.\"\n}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "DCF Valuation Model",
          "risks": [
            "Integration failures from aggressive M&A strategy",
            "Prolonged economic recession reducing client spending",
            "Increased competition eroding market share",
            "Regulatory shifts increasing compliance costs",
            "Interest rate volatility affecting debt servicing"
          ],
          "ticker": "BRO",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.5,
              "notes": "Consistent execution on organic growth and M&A.",
              "target_price": 80
            },
            "bear": {
              "prob": 0.25,
              "notes": "Growth slows amid recession and acquisition challenges.",
              "target_price": 58
            },
            "bull": {
              "prob": 0.25,
              "notes": "Accelerated growth from strong insurance market.",
              "target_price": 98
            }
          },
          "confidence": 0.62,
          "assumptions": {
            "wacc": 0.085,
            "revenue_cagr_3y": 0.14,
            "terminal_multiple": 19,
            "ebit_margin_target": 0.3
          },
          "key_drivers": [
            {
              "driver": "Organic revenue growth",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Strategic acquisitions",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Rising insurance premiums",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Economic downturn impact",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Margin expansion",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Debt levels and interest costs",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Competitive landscape",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Regulatory environment",
              "impact": "MED",
              "direction": "NEG"
            }
          ],
          "method_notes": "DCF using 14% revenue CAGR, 30% EBIT margin, 8.5% WACC and 19x terminal multiple. 18% 12M upside supports BUY. Consensus noted but not used in targets. not investment advice.",
          "current_price": 67.76,
          "recommendation": "BUY",
          "thesis_bullets": [
            "Strong revenue growth of 23% yoy from organic and M&A",
            "Stable business model with recurring revenue streams",
            "Forward PE of 17.5x appears reasonable for growth profile",
            "Low beta of 0.7 offers portfolio diversification",
            "Robust cash flow funds dividends and debt management"
          ],
          "target_price_6m": 73,
          "target_price_12m": 80
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "provider": "xai",
            "webSearch": {
              "used": false,
              "enabled": false,
              "sources": [],
              "maxToolCalls": 2
            },
            "responseId": "7f8b47dc-067a-930b-8e83-4b41c389470b",
            "usedFallbackChatCompletions": false
          },
          "sanityIssues": []
        },
        "latencyMs": 25437,
        "createdAt": "2026-04-09T05:19:51.139Z",
        "usage": {
          "inputTokens": 2694,
          "outputTokens": 3891,
          "costUsd": 0.066447
        }
      }
    ]
  }
}